# MediciNova, Inc. (MNOV)

> Source: Nexqual · https://nexqual.com/MNOV · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, MediciNova, Inc. (MNOV), nexqual.com/MNOV" · informational, not investment advice.

**Price:** USD 1.45 (-1.36% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.47 · day 1.45–1.53 · 52w 1.17–3.9 · market cap $71.4M · NGM

## Key facts
- Analysts: Buy (mean 1.75 on a 1–5 scale) (4 analysts), mean target USD 8.25 (range 6–11).
- Total return with dividends: 1Y +16.0% vs S&P 500 +18.1%; 5Y -62.0% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.06, revenue estimate $50K.

## Analysts
Consensus Buy (mean 1.75 on a 1–5 scale), 4 analysts; mean target USD 8.25 (low 6, high 11).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-17 | Roth Capital | Initiated | Buy | $6 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +16.0% | -62.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +16.1% | -17.6% |
| Volatility (annualized) | 80.5% | 60.4% |
| Max drawdown | -58.0% (Sep 2026→Oct 2026) | -69.6% (Oct 2021→Aug 2024) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/MNOV · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt